AnaptysBio forges antibody pact with Celgene; KV chief garners $130K bonus;

@FierceBiotech: Optimer Pharma ousts chairman, top execs over a grant of shares in affiliate. News | Follow @FierceBiotech

@JohnCFierce: Lilly's Amyvid OK'd to rule out Alzheimer's, but not to diagnose the disease, which neatly captures the R&D challenge. More | Follow @JohnCFierce

@RyanMFierce: Good piece in @Forbes this morning on India's open source drug discovery unit, where online tools are used to find new drugs: Item | Follow @RyanMFierce

> AnaptysBio announced a strategic partnership with Celgene ($CELG) to develop novel antibodies against multiple therapeutic targets. Release

> KV Pharmaceutical CEO Greg Divis was awarded a $130,000 cash bonus by the board. Report

> Presage Biosciences has struck a cancer research deal with Millennium, providing the Takeda company with access to its tech platform to enable non-clinical identification of effective novel oncology drug combinations in solid tumors. Release

> Ampio ($AMPE) submitted a pre-IND package to the FDA on Zertane, its on-demand premature ejaculation drug. Release

Pharma News

@FiercePharma: Ranbaxy's knockoff version of Lipitor outsells Pfizer's ($PFE) branded pills, with Watson in distant 3rd place--WSJ. Article | Follow @FiercePharma

> After losing CEO race to Gorsky, J&J's McCoy jumps ship. News

> Purdue plots $100M ad push for new sleep drug. Story

> Novartis CEO explains how and why he cut jobs. Item

Medical Devices News

@FierceMedDev: Texas Instruments Gift Leads to New Biomedical Device Center | University of Texas at Dallas. Piece | Follow @FierceMedDev

> St. Jude demands retraction of Riata lead study. News

> Doctors overuse invasive heart test, study says. Item

> FDA approves Lilly's brain plaque diagnostic tool. News

> Teleflex launches catheter positioning device in EU. More

IT News

> Gotham's genome center grabs grant for bioinformatics hires. Story

> Radiant Sage finds big software need for Pfizer. Article

> New frontier in digitized clinical trials: Video games? Item

> Roche helps corral diabetes chitchat from Twitter. Story

> Apple emerges as 'dominant' life sciences IT player. More

And Finally... Scientists at Trinity College Dublin found that a part of the immune system called the inflammasome is involved in regulating the development of age-related macular degeneration (AMD). And they say that controlling an inflammatory component of IL-18 in cases of AMD could prevent the development of the disease. Release

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.